(3S,4R,5R)-5-[[(4S,5S,6R)-4-[(3S,4S,5R)-5-[(3S,4R,5R)-5-[[(4S,5S,6R)-4-[(3S,4S,5R)-5-[(3S,4R,5R)-3,4-dihydroxy-6-methyl-5-[[(4S,5R,6R)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]-3,4-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]-6-methyloxane-2,3,4-triol

Details

Top
Internal ID cca1ec45-73e1-4fd9-bf6e-26f62d70bd5a
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Aminosaccharides > Aminoglycosides > Aminocyclitol glycosides
IUPAC Name (3S,4R,5R)-5-[[(4S,5S,6R)-4-[(3S,4S,5R)-5-[(3S,4R,5R)-5-[[(4S,5S,6R)-4-[(3S,4S,5R)-5-[(3S,4R,5R)-3,4-dihydroxy-6-methyl-5-[[(4S,5R,6R)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]-3,4-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]-6-methyloxane-2,3,4-triol
SMILES (Canonical) CC1C(C(C(C(O1)O)O)O)NC2C=C(C(C(C2O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C)NC5C=C(C(C(C5O)O)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)C)NC8C=C(C(C(C8O)O)O)CO)O)O)O)O)CO)O)O)O)O)CO
SMILES (Isomeric) CC1[C@@H]([C@H]([C@@H](C(O1)O)O)O)NC2C=C([C@@H]([C@H]([C@@H]2O)O)OC3[C@H]([C@@H]([C@H](C(O3)CO)OC4[C@H]([C@@H]([C@H](C(O4)C)NC5C=C([C@@H]([C@H]([C@@H]5O)O)OC6[C@H]([C@@H]([C@H](C(O6)CO)OC7[C@H]([C@@H]([C@H](C(O7)C)NC8C=C([C@@H]([C@H]([C@@H]8O)O)O)CO)O)O)O)O)CO)O)O)O)O)CO
InChI InChI=1S/C51H85N3O32/c1-12-23(30(64)38(72)47(77)78-12)53-19-5-16(8-56)43(34(68)28(19)62)83-50-41(75)37(71)46(22(11-59)81-50)86-49-40(74)32(66)25(14(3)80-49)54-20-6-17(9-57)44(35(69)29(20)63)84-51-42(76)36(70)45(21(10-58)82-51)85-48-39(73)31(65)24(13(2)79-48)52-18-4-15(7-55)26(60)33(67)27(18)61/h4-6,12-14,18-77H,7-11H2,1-3H3/t12?,13?,14?,18?,19?,20?,21?,22?,23-,24-,25-,26-,27+,28+,29+,30+,31+,32+,33+,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47?,48?,49?,50?,51?/m0/s1
InChI Key ADVPSQKLMVHHOI-JNZKTNTDSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C51H85N3O32
Molecular Weight 1252.20 g/mol
Exact Mass 1251.5116175 g/mol
Topological Polar Surface Area (TPSA) 584.00 Ų
XlogP -16.10
Atomic LogP (AlogP) -14.90
H-Bond Acceptor 35
H-Bond Donor 26
Rotatable Bonds 19

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (3S,4R,5R)-5-[[(4S,5S,6R)-4-[(3S,4S,5R)-5-[(3S,4R,5R)-5-[[(4S,5S,6R)-4-[(3S,4S,5R)-5-[(3S,4R,5R)-3,4-dihydroxy-6-methyl-5-[[(4S,5R,6R)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]-3,4-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]-6-methyloxane-2,3,4-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.9754 97.54%
Caco-2 - 0.8658 86.58%
Blood Brain Barrier - 0.8250 82.50%
Human oral bioavailability - 0.8857 88.57%
Subcellular localzation Mitochondria 0.5701 57.01%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8528 85.28%
OATP1B3 inhibitior + 0.9485 94.85%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior + 0.8877 88.77%
P-glycoprotein inhibitior + 0.7311 73.11%
P-glycoprotein substrate - 0.6092 60.92%
CYP3A4 substrate + 0.6215 62.15%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8060 80.60%
CYP3A4 inhibition - 0.9488 94.88%
CYP2C9 inhibition - 0.8751 87.51%
CYP2C19 inhibition - 0.8569 85.69%
CYP2D6 inhibition - 0.8805 88.05%
CYP1A2 inhibition - 0.8952 89.52%
CYP2C8 inhibition - 0.5804 58.04%
CYP inhibitory promiscuity - 0.7643 76.43%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.5881 58.81%
Eye corrosion - 0.9888 98.88%
Eye irritation - 0.8998 89.98%
Skin irritation - 0.8104 81.04%
Skin corrosion - 0.9409 94.09%
Ames mutagenesis + 0.5200 52.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8362 83.62%
Micronuclear + 0.7000 70.00%
Hepatotoxicity + 0.8750 87.50%
skin sensitisation - 0.8663 86.63%
Respiratory toxicity + 0.6667 66.67%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity + 0.8125 81.25%
Nephrotoxicity - 0.8382 83.82%
Acute Oral Toxicity (c) III 0.4651 46.51%
Estrogen receptor binding + 0.8141 81.41%
Androgen receptor binding + 0.6993 69.93%
Thyroid receptor binding + 0.6116 61.16%
Glucocorticoid receptor binding + 0.6781 67.81%
Aromatase binding + 0.6273 62.73%
PPAR gamma + 0.7899 78.99%
Honey bee toxicity - 0.6476 64.76%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.6400 64.00%
Fish aquatic toxicity - 0.7631 76.31%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.12% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 96.23% 95.93%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 94.74% 96.09%
CHEMBL3401 O75469 Pregnane X receptor 93.27% 94.73%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 91.73% 86.92%
CHEMBL3714130 P46095 G-protein coupled receptor 6 85.81% 97.36%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 83.47% 95.83%
CHEMBL1293255 P15428 15-hydroxyprostaglandin dehydrogenase [NAD+] 81.72% 83.57%
CHEMBL4208 P20618 Proteasome component C5 81.63% 90.00%
CHEMBL2563 Q9UQL6 Histone deacetylase 5 80.16% 89.67%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 163070002
LOTUS LTS0118939
wikiData Q104909831